机译:用Neoadjuvant Vismodegib与局部晚期围眼基础细胞癌的眼科保存
Univ Texas MD Anderson Canc Ctr Dept Plast Surg Orbital Oncol &
Ophthalm Plast Surg Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Head &
Neck Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Plast Surg Orbital Oncol &
Ophthalm Plast Surg Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Plast Surg Orbital Oncol &
Ophthalm Plast Surg Houston TX;
Univ Texas MD Anderson Canc Ctr Dept Head &
Neck Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Head &
Neck Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Plast Surg Orbital Oncol &
Ophthalm Plast Surg Houston TX;
机译:用Neoadjuvant Vismodegib与局部晚期围眼基础细胞癌的眼科保存
机译:Neoadjuvant Vismodegib和Mohs微观手术,用于局部晚期的围眼基础细胞癌
机译:Vismodegib用于保存高级围眼基础细胞癌患者的视觉功能:Visorb试验
机译:CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
机译:强烈的Neoadjuvant治疗局部晚期癌症射线=加强Neoadjuvant治疗局部晚期直肠癌
机译:Vismodegib用于保存高级围眼基础细胞癌患者的视觉功能:Visorb试验
机译:Vismodegib用于局部晚期眼周和眼眶基底细胞癌:15例连续病例回顾